Interferon-γ induces upregulation and activation of the interleukin-31 receptor in human dermal microvascular endothelial cells - Feld - 2010 - Experimental Dermatology - Wiley Online Library

Links shared publicly online about this topic.

  • 864
    total visits

Interferon-γ induces upregulation and activation of the interleukin-31 receptor in human dermal microvascular endothelial cells - Feld - 2010 - Experimental Dermatology - Wiley Online Library

onlinelibrary.wiley.com

Interferon-γ induces upregulation and activation of the interleukin-31 receptor in human dermal microvascular endothelial cells - Feld - 2010 - Experimental Dermatology - Wiley Online Library

View full resource at onlinelibrary.wiley.com

Tags: Dermatology

  • Share

Most Recently Shared on September 18, 2010 at 2:24 pm By:

Dermatology_OW Dermatology Wisdom

Interferonâ€*γ induces upregulation and activation of the interleukinâ€*31 receptor in human dermal microvascular... http://bit.ly/bfgvPj

2 years ago...

Manage Account - ModernMedicine

modernmedicine.com — “NEW YORK (Reuters Health) - Interferon-gamma release assays (IGRAs) are significantly better than tuberculin skin tests (TST) at predicting progression from latent tuberculosis (TB), a new meta-analysis from Germany shows.View full resource at modernmedicine.com

  • View Related
  • Share

Most Recently Shared on May 10, 2012 at 9:34 pm By:

ingentaconnect Rapid diagnosis of Mycobacterium tuberculosis infection in childr...

ingentaconnect.com — “ingentaconnect Rapid diagnosis of Mycobacterium tuberculosis infection in childr...View full resource at ingentaconnect.com

  • View Related
  • Share

Most Recently Shared on May 10, 2012 at 5:06 pm By:

Asthma_Wisdom Asthma OW OW Health

Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs... http://t.co/3e3Dv80H

3 weeks ago...

Patient Trial For New Asthma Treatment Yields Positive Results

medicalnewstoday.com — “Scientists from the University of Southampton and Synairgen, a respiratory drug development company spun out from the University, can announce positive data from its Phase II clinical trial, intoView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 21, 2012 at 7:05 am By:

mnt_diseases MNT Infect Diseases Health News

Patient Trial For New Asthma Treatment Yields Positive Results http://t.co/L0EvtrID #viruses #bacteria

1 month ago...

Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS

eurekalert.org — “People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21-28, 2012.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on April 20, 2012 at 7:17 am By:

Neurology_OW Neurology OW OW Health

Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS: ( American Acade... http://t.co/DJO0pAcf

1 month ago...

Early Use of MS Drug May Cut Likelihood of Progression --Doctors Lounge

doctorslounge.com — “Early Use of MS Drug May Cut Likelihood of Progression --Doctors LoungeView full resource at doctorslounge.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 9:27 pm By:

Health_News_OW Health News OW OW Health

Early Use of MS Drug May Cut Likelihood of Progression: Study found fewer people given 'interferon beta-1a' earl... http://t.co/QoQs8sY7

1 month ago...

Early Use of MS Drug May Cut Likelihood of Progression --Doctors Lounge

doctorslounge.com — “Early Use of MS Drug May Cut Likelihood of Progression --Doctors LoungeView full resource at doctorslounge.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 9:06 pm By:

DoctorsLounge Doctors Lounge Support

Early Use of MS Drug May Cut Likelihood of Progression http://t.co/37ykQFu5 #health #medicine

1 month ago...

Interferon-Free Hepatitis C Trial Achieves 82% Viral Cure

medicalnewstoday.com — “According to new data from the largest Phase II interferon-free trial to date, after only 28 weeks of treatment, almost 82% of hepatitis C patients achieved a viral cure. The results were achieveView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 8:05 pm By:

mnt_healthnews MNT Health News Health News

Interferon-Free Hepatitis C Trial Achieves 82% Viral Cure http://t.co/PMIB5efb #healthnews

1 month ago...

HCV New Drug Research: EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin

hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirinView full resource at hepatitiscnewdrugs.blogspot.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 4:12 pm By:

HCVNEWDRUGS Tina Banwart - HepatitisCNewDrugs Health Blog

EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the… http://t.co/es8fhWgM

1 month ago...

HCV New Drug Research: EASL-BI 201335 and BI 207127-Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*)

hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL-BI 201335 and BI 207127-Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*)View full resource at hepatitiscnewdrugs.blogspot.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 4:12 pm By:

HCVNEWDRUGS Tina Banwart - HepatitisCNewDrugs Health Blog

EASL-BI 201335 and BI 207127-Viral cure achieved without interferon in up to 82% of hepatitis… http://t.co/p3KdpuhG

1 month ago...

HCV New Drug Research: EASL:Hepatitis C-NEW DATA SUGGESTS INTERFERON-FREE THERAPY AROUND THE CORNER

hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL:Hepatitis C-NEW DATA SUGGESTS INTERFERON-FREE THERAPY AROUND THE CORNERView full resource at hepatitiscnewdrugs.blogspot.com

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 3:10 pm By:

HCVNEWDRUGS Tina Banwart - HepatitisCNewDrugs Health Blog

EASL:Hepatitis C-NEW DATA SUGGESTS INTERFERON-FREE THERAPY AROUND THE CORNER http://t.co/4I9kPBDl

1 month ago...

Clinical Neurology News - January 2012 - (12)

nxtbook.com — “Digital EditionView full resource at nxtbook.com

  • View Related
  • Share

Most Recently Shared on March 31, 2012 at 2:26 am By:

MedWire News - Infectious Diseases - Human gene variant can transform mild flu into serious disease

medwire-news.md — “MedWire News People with a specific variant of the interferon-inducible transmembrane 3 gene are more likely to be hospitalized with seasonal or pandemic influenza than noncarriers, suggest study results published in Nature. MedWire NewsView full resource at medwire-news.md

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 1:30 pm By:

MedWireNews MedWire News Health News

Human gene variant can transform mild flu into serious disease http://t.co/mPbJZlLN

2 months ago...

Endocrinology News - Low Density Lipoprotein Apheresis Ameliorates Interferon- Production in Patients With Nephrotic Syndrome |3966075

mdlinx.com — “Endocrinology Medical Article: Low Density Lipoprotein Apheresis Ameliorates Interferon- Production in Patients With Nephrotic SyndromeView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 6:52 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Low Density Lipoprotein Apheresis Ameliorates Interferon- Production in Patients With Nephrotic Syndrome: ... http://t.co/rT4osgTS #endo

2 months ago...

Early predictors of non-response to interferon in multiple sclerosis - Horakova - 2012 - Acta Neurologica Scandinavica - Wiley Online Library

onlinelibrary.wiley.com — “Early predictors of non-response to interferon in multiple sclerosis - Horakova - 2012 - Acta Neurologica Scandinavica - Wiley Online LibraryView full resource at onlinelibrary.wiley.com

  • View Related
  • Share

Most Recently Shared on March 17, 2012 at 1:11 am By:

MS_Wisdom2 OrganizedWisdom MS OW Health

Early predictors of non‐response to interferon in multiple sclerosis: ConclusionsIn patients with MS treated wit... http://t.co/33hqr76W

3 months ago...

Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts

rheumatology.oxfordjournals.org — “Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcriptsView full resource at rheumatology.oxfordjournals.org

  • View Related
  • Share

Most Recently Shared on March 17, 2012 at 1:11 am By:

RA_Wisdom OrganizedWisdom RA OW Health

Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with ... http://t.co/pn3yTm18

3 months ago...

Advertisement